Complications of androgen-deprivation therapy in men with prostate cancer
- PMID: 15869725
- DOI: 10.1007/s11934-005-0009-2
Complications of androgen-deprivation therapy in men with prostate cancer
Abstract
Androgen-deprivation therapy (ADT) is indicated for the treatment of metastatic prostate cancer and locally advanced disease. In addition to sexual side effects, long-term ADT results in several other changes, including hot flashes; gynecomastia; changes in body composition, metabolism, and the cardiovascular system; osteoporosis; anemia; psychiatric and cognitive problems; and fatigue and diminished quality of life. This review discusses these complications of ADT and treatments aimed at reducing them. It is important for clinicians to anticipate these effects and to initiate measures to prevent or minimize them in order to maintain quality of life in prostate cancer survivors.
Similar articles
-
Complications of androgen deprivation therapy in men with prostate cancer.Curr Oncol Rep. 2004 May;6(3):209-15. doi: 10.1007/s11912-004-0051-0. Curr Oncol Rep. 2004. PMID: 15066232 Review.
-
Preventing and treating the complications of hormone therapy.Curr Urol Rep. 2005 May;6(3):217-23. doi: 10.1007/s11934-005-0010-9. Curr Urol Rep. 2005. PMID: 15869726 Review.
-
Adverse effects of androgen deprivation therapy and strategies to mitigate them.Eur Urol. 2015 May;67(5):825-36. doi: 10.1016/j.eururo.2014.07.010. Epub 2014 Aug 2. Eur Urol. 2015. PMID: 25097095 Review.
-
Acupuncture for hot flashes in men treated with androgen deprivation therapy.Can J Urol. 2015 Aug;22(4):7938-41. Can J Urol. 2015. PMID: 26267037
-
Emerging cardiometabolic complications of androgen deprivation therapy.Aging Male. 2010 Mar;13(1):1-9. doi: 10.3109/13685530903410625. Aging Male. 2010. PMID: 20148744 Review.
Cited by
-
Do hormone treatments for prostate cancer cause anxiety and depression?Int J Clin Oncol. 2014;19(3):523-30. doi: 10.1007/s10147-013-0569-y. Epub 2013 Jun 1. Int J Clin Oncol. 2014. PMID: 23728883 Clinical Trial.
-
Quality of life issues in men undergoing androgen deprivation therapy: a review.Asian J Androl. 2012 Mar;14(2):226-31. doi: 10.1038/aja.2011.108. Epub 2012 Jan 9. Asian J Androl. 2012. PMID: 22231296 Free PMC article. Review.
-
A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.BMC Cancer. 2012 Mar 21;12:103. doi: 10.1186/1471-2407-12-103. BMC Cancer. 2012. PMID: 22436542 Free PMC article. Clinical Trial.
-
Effects of Baduanjin exercise on cancer-related fatigue in patients with prostate cancer treated with androgen deprivation therapy in Shanghai, China: a study protocol for a randomised controlled trial.BMJ Open. 2024 Nov 13;14(11):e092363. doi: 10.1136/bmjopen-2024-092363. BMJ Open. 2024. PMID: 39537565 Free PMC article.
-
Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer.Bioorg Med Chem. 2008 Mar 15;16(6):2764-8. doi: 10.1016/j.bmc.2008.01.012. Epub 2008 Jan 11. Bioorg Med Chem. 2008. PMID: 18249125 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical